England's NICE is recommending natalizumab, sold as Tysabri and Tyruko, as an NHS-covered treatment option for people with ...
Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...
NICE recommends natalizumab as a new treatment for adults with highly active relapsing-remitting multiple sclerosis ...
At Multiple Sclerosis News Today, stories about the keto diet, myelin repair, and vitamin D topped this year's most-read list ...
Scientists have used AI to identify two novel subtypes of multiple sclerosis (MS), which could offer new, targeted treatments ...
Patients included in a new study were grouped by initiation of high-efficacy or moderate-efficacy disease-modifying therapy (DMT). The most common reasons for DMT de-escalation were positivity for JC ...
Multiple sclerosis (MS) treatment could be on the brink of a significant breakthrough thanks to innovative research by Immunic Therapeutics. Speaking to Fierce Pharma, CEO Daniel Vitt shares insights ...
As the multiple sclerosis (MS) population ages, managing the condition can bring new challenges. For one woman, working closely with her doctor, exploring treatment options, and finding the right ...
"The observed differential effects of high-efficacy disease-modifying agents across sexes underscore the importance of sex-specific considerations in making treatment decisions to personalize care in ...
He revealed more recently he had bio-cellular therapy treatment on his spine Kevin Winter/Getty Jack Osbourne is opening up about his Multiple Sclerosis (MS) diagnosis. The 38-year-old media ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback